Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Co-Chief Executive Officer, Director
-
Stock Symbol
-
AMLX on Nasdaq
Joshua B. Cohen - trading volume in the past year for Amylyx Pharmaceuticals, Inc.
Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
3.33M |
$49.9M |
$15.00 |
Sep 30, 2025 |
Direct |
|
|
Stock Option (Right to Buy) |
270K |
|
|
Mar 6, 2025 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.